シスタチンC測定法市場：製品タイプ、測定法、サンプルタイプ、設定、用途、エンドユーザー別-2025-2030年世界予測

シスタチンC測定法市場は、2023年に4億2,747万米ドルと評価され、2024年には4億5,983万米ドルに達すると予測され、CAGR 7.24%で成長し、2030年には6億9,741万米ドルに達すると予測されています。

シスタチンC測定法は、腎機能を反映するタンパク質であるシスタチンCのレベルを測定するために使用される医療診断ツールであり、従来のクレアチニン検査よりも正確な評価を提供します。この検査法の必要性は、腎機能の低下についてより早く正確な情報を提供できることにあり、慢性腎臓病（CKD）のモニタリング、心血管リスクの評価、腎臓内科の研究などの用途に不可欠です。最終用途には、病院、診断研究所、研究機関が含まれます。CKDの有病率の上昇、人口の高齢化、正確な診断に対する需要の増加が市場を牽引しています。成長に影響を与える主な要因としては、測定技術の進歩、腎臓の健康に対する意識の高まり、日常健康診断におけるシスタチンC検査の統合などが挙げられます。最新のビジネスチャンスは、ヘルスケアのインフラが改善しつつある新興市場や、ライフスタイル要因によるCKDの発症率が高い地域で見られます。さらに、遺伝子マーカーとシスタチンCを統合したコンビネーションアッセイの開発は、個別化医療の動向を取り込む可能性があります。

しかし、高コスト、新興国市場における医療従事者の認識不足、標準化されていない検査方法による検査結果のばらつきといった課題が、市場の成長を阻害する可能性があります。技術的進歩によるコスト削減、検査スピードと精度の向上といった分野でのイノベーションが必要です。新興市場のヘルスケア・プロバイダーに対する教育やトレーニングに投資することで、アッセイの利点をより明確にし、普及させることができ、採用が拡大する可能性があります。市場は現在、絶え間ない技術革新と規制上の課題によって競争が激しく断片化しているが、バイオテクノロジー企業との提携やポータブルまたはポイントオブケア検査ソリューションへの注力によって拡大の機会が存在します。全体として、早期診断と慢性疾患管理におけるアプリケーションの拡大が、市場の軌道を維持・強化すると思われます。

市場力学：急速に進化するシスタチンC測定法市場の主要市場インサイトを公開

シスタチンC測定法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 腎臓疾患の有病率の上昇と老年人口の増加
  • 腎疾患のヘルスケアインフラへの投資の進展
• 市場抑制要因
  • シスタチンC測定法の開発コストの高さと製品リコールの発生
• 市場機会
  • シスタチンC測定法検査の進歩
  • クレアチニンベースの検査に代わるシスタチンC測定法の採用に関する調査の開始
• 市場の課題
  • 熟練した検査専門家の不足とシスタチンC測定法に関連する技術的課題

ポーターの5つの力：シスタチンC測定法市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、シスタチンC測定法市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：シスタチンC測定法市場における外部からの影響の把握

外部マクロ環境要因は、シスタチンC測定法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析シスタチンC測定法市場における競合情勢の把握

シスタチンC測定法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスシスタチンC測定法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、シスタチンC測定法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腎臓疾患の罹患率の上昇と高齢者人口の増加
    • 腎疾患のヘルスケアインフラへの積極的な投資
  • 抑制要因
    • シスタチンCアッセイの開発コストの高さと製品リコールの発生率
  • 機会
    • シスタチンC測定法テストの進歩
    • クレアチニンベースの検査の代替としてシスタチンC検査を採用するための新たな調査
  • 課題
    • 熟練した研究室専門家の不足とシスタチンC測定法に関連する技術的な課題
• 市場セグメンテーション分析
  • 製品：診断および状態監視用の消費者好みのシスタチンC分析装置
  • 方法：シスタチンCアッセイにおける酵素結合免疫吸着測定法（ELISA）の利用拡大
  • 設定：シスタチンCアッセイのポイントオブケア設定の使用拡大
  • サンプルタイプ：サンプル中のクレアチニンの量を測定するためのシスタチンC測定法の重要な役割の尿サンプル
  • 応用：腎機能診断におけるシスタチンCアッセイの応用拡大
  • エンドユーザー：バイオマーカー研究のための学術研究センターにおけるシスタチンCアッセイの利用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 シスタチンC測定法市場：製品別

• アナライザ
• キット
• 試薬

第7章 シスタチンC測定法市場：方法別

• 化学発光免疫測定法
• 酵素免疫測定法
• 免疫蛍光アッセイ
• 粒子増強比濁免疫測定法
• 粒子増強比濁免疫測定法

第8章 シスタチンC測定法市場サンプルタイプ別

• 血
• 尿

第9章 シスタチンC測定法市場設定により

• 実験室の設定
• ポイントオブケア設定

第10章 シスタチンC測定法市場：用途別

• 診断の使用
• 研究開発

第11章 シスタチンC測定法市場：エンドユーザー別

• 学術研究センター
• 診断検査室
• 病院・クリニック

第12章 南北アメリカのシスタチンC測定法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域のシスタチンC測定法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカのシスタチンC測定法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ジャナ・ケア、自己採血検査の商業化に向けて600万米ドルを調達
  • ロードスメッド、マハラシュトラ州初の病理学センター開設を発表
  • Renalyse、GENESIS Venturesの参加を得て100万ユーロの資金調達ラウンドを完了
  • Renalytix社、2型糖尿病患者の腎臓病の早期予後検出のためのKidneyIntelXの商業化拡大にEVERSANA社を選択
  • eGFRの新しい欧州シスタチンC式はより正確になる可能性がある
  • ジャナ・ケア、ロシュと提携し、慢性腎臓病および心臓病患者の遠隔ケア改善に向けた血液検査プラットフォームの開発と配布を開始
  • ゲンティアン・ダイアグノスティクス ASAがシスタチンCの販売契約を締結
  • ブルーム・ダイアグノスティクス、新たな腎臓検査を発表

企業一覧

• Abbexa Limited
• Abbott Laboratories
• Abcam PLC
• Advy Chemical Pvt. Ltd.
• Agilent Technologies, Inc.
• AOBIOUS Inc.
• Arbor Assays Inc.
• Aviva Systems Biology Corporation
• BBI Solutions OEM Limited
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Biorbyt Ltd
• BioVendor-Laboratorni medicina a.s.
• Boditech Med Inc.
• Cepham Life Sciences, Inc.
• Cusabio Technology LLC
• DIALAB GmbH
• DiaSys Diagnostic Systems GmbH
• Diazyme Laboratories, Inc. by General Atomics
• Eagle Biosciences, Inc.
• Elabscience Biotechnology Inc.
• Ethos Biosciences, Inc.
• Eurolyser Diagnostica GmbH by Mars, Incorporated
• F. Hoffmann-La Roche Ltd
• Fapon Biotech Inc.
• Fortress Diagnostics Ltd.
• Gentian Diagnostics ASA
• Getein Biotech, Inc.
• ImmunoDiagnostics Limited
• Kamiya Biomedical Company
• Laboratory Corporation of America Holdings
• Merck KGaA
• Proteintech Group, Inc.
• PZ CORMAY S.A.
• Randox Laboratories Ltd.
• RayBiotech, Inc.
• Sekisui Diagnostics, LLC
• Siemens Healthineers AG
• Sino Biological, Inc.
• Thermo Fisher Scientific Inc.
• Tosoh Corporation
• Weldon Biotech
• Zhejiang Kangte Biotechnology Co., Ltd.

LIST OF FIGURES

• FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
• FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
• FIGURE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 6. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 18. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 20. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 22. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 26. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
• TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 6. CYSTATIN C ASSAY MARKET DYNAMICS
• TABLE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 19. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 20. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 21. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 22. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 23. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 24. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 25. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 26. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 27. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 28. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 29. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 30. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 31. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 32. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 33. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 34. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 35. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 36. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 37. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 38. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 39. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 40. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 41. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 42. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 43. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 44. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 45. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 46. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 47. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 48. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 49. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 50. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 51. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 52. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 53. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 54. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 55. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 56. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 57. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 58. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 59. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 60. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 61. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 62. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 63. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 64. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 65. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 66. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 67. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
• TABLE 68. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 69. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 70. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 71. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 72. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 73. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 74. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 75. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 76. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 77. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 78. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 79. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 80. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 81. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 82. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 83. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 84. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 85. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 86. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 87. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 88. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 89. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 90. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 91. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 92. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 93. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 94. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 95. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 96. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 97. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 98. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 99. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 100. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 101. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 102. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 103. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 104. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 105. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 106. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 107. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 108. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 109. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 110. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 111. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 112. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 113. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 114. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 115. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 116. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 117. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 118. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 119. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 120. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 121. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 122. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 123. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 124. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 125. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 126. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 127. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 128. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 129. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 130. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 131. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 132. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 133. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 134. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 135. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 136. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 137. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 138. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 139. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 140. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 141. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 142. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 143. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 144. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 145. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 146. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 154. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 155. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 156. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 157. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 158. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 159. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 160. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 161. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 162. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 163. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 164. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 165. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 166. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 167. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 168. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 169. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 170. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 171. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 172. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 173. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 174. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 175. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 176. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 177. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 178. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 179. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 180. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 181. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 182. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 183. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 184. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 185. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 186. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 187. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 188. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 189. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 190. ITALY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 191. ITALY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 192. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 193. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 194. ITALY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 195. ITALY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 196. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 197. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 198. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 199. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 200. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 201. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 202. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 203. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 204. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 205. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 206. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 207. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 208. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 209. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 210. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 211. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 212. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 213. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 214. POLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 215. POLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 216. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 217. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 218. POLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 219. POLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 220. QATAR CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 221. QATAR CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 222. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 223. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 224. QATAR CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 225. QATAR CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 226. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 227. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 228. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 229. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 230. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 231. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 232. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 233. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 234. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 235. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 236. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 237. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 238. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 239. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 240. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 241. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 242. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 243. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 244. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 245. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 246. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 247. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 248. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 249. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 250. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 251. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 252. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 253. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 254. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 255. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 256. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 257. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 258. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 259. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 260. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 261. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 262. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 263. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 264. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 265. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 266. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 267. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 268. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 269. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 270. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 271. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 272. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 273. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 274. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 275. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
• TABLE 276. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 277. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
• TABLE 278. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 279. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 280. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 281. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

The Cystatin C Assay Market was valued at USD 427.47 million in 2023, expected to reach USD 459.83 million in 2024, and is projected to grow at a CAGR of 7.24%, to USD 697.41 million by 2030.

A Cystatin C Assay is a medical diagnostic tool used to measure levels of cystatin C, a protein that reflects kidney function, providing a more accurate assessment than traditional creatinine tests. The necessity of this assay lies in its ability to offer earlier and precise information about declining renal function, making it essential in applications such as chronic kidney disease (CKD) monitoring, cardiovascular risk assessment, and research in nephrology. The end-use scope encompasses hospitals, diagnostic laboratories, and research institutes. The market is primarily driven by the rising prevalence of CKD, an aging population, and increasing demand for accurate diagnostics. Key influencing growth factors include advancements in assay technologies, heightened awareness about kidney health, and the integration of cystatin C testing within routine health check-ups. Latest opportunities are seen in emerging markets where healthcare infrastructure is improving and in regions witnessing a higher incidence of CKD due to lifestyle factors. Additionally, the development of combination assays that integrate genetic markers and cystatin C could tap into personalized medicine trends.

However, challenges like high costs, lack of awareness among medical professionals in developing regions, and variability in assay results due to non-standardized testing methods can impede market growth. Innovations are necessary in areas such as cost reduction through technological advances and enhancement of assay speed and accuracy. Investing in education and training for healthcare providers in emerging markets could better identify and promote the assay's benefits, broadening its adoption. The market is currently competitive and fragmented, driven by constant innovation and regulatory challenges, but opportunities for expansion exist through collaborations with biotech firms and focus on portable or point-of-care testing solutions. Overall, expanding applications in early diagnosis and chronic disease management will sustain and enhance market trajectory.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystatin C Assay Market

The Cystatin C Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of kidney diseases and growing geriatric population
  • Progressive investments in healthcare infrastructures for renal disorders
• Market Restraints
  • High development costs of cystatin C assays and incidences of product recalls
• Market Opportunities
  • Advances in cystatin C assay testing
  • Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
• Market Challenges
  • Dearth of skilled lab professionals and technical challenges associated with cystatin C assay

Porter's Five Forces: A Strategic Tool for Navigating the Cystatin C Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystatin C Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystatin C Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystatin C Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystatin C Assay Market

A detailed market share analysis in the Cystatin C Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystatin C Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystatin C Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorni medicina a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Analyzer, Kits, and Reagents.
• Based on Method, market is studied across Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay, Particle-enhanced Nephelometric Immunoassay, and Particle-enhanced Turbidimetric Immunoassay.
• Based on Sample Type, market is studied across Blood and Urine.
• Based on Setting, market is studied across Laboratory Setting and Point of Care Setting.
• Based on Application, market is studied across Diagnosis Use and Research & Development.
• Based on End-user, market is studied across Academic Research Centers, Diagnostic Laboratories, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
    • 5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
  • 5.1.2. Restraints
    • 5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in cystatin C assay testing
    • 5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
  • 5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
  • 5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
  • 5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
  • 5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
  • 5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cystatin C Assay Market, by Product

• 6.1. Introduction
• 6.2. Analyzer
• 6.3. Kits
• 6.4. Reagents

7. Cystatin C Assay Market, by Method

• 7.1. Introduction
• 7.2. Chemiluminescence Immunoassay
• 7.3. Enzyme linked Immunosorbent Assay
• 7.4. Immunofluorescence Assay
• 7.5. Particle-enhanced Nephelometric Immunoassay
• 7.6. Particle-enhanced Turbidimetric Immunoassay

8. Cystatin C Assay Market, by Sample Type

• 8.1. Introduction
• 8.2. Blood
• 8.3. Urine

9. Cystatin C Assay Market, by Setting

• 9.1. Introduction
• 9.2. Laboratory Setting
• 9.3. Point of Care Setting

10. Cystatin C Assay Market, by Application

• 10.1. Introduction
• 10.2. Diagnosis Use
• 10.3. Research & Development

11. Cystatin C Assay Market, by End-user

• 11.1. Introduction
• 11.2. Academic Research Centers
• 11.3. Diagnostic Laboratories
• 11.4. Hospitals & Clinics

12. Americas Cystatin C Assay Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Cystatin C Assay Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Cystatin C Assay Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
  • 15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
  • 15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
  • 15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
  • 15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
  • 15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
  • 15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
  • 15.3.8. Bloom Diagnostics Launches New Kidney Test

Companies Mentioned

• 1. Abbexa Limited
• 2. Abbott Laboratories
• 3. Abcam PLC
• 4. Advy Chemical Pvt. Ltd.
• 5. Agilent Technologies, Inc.
• 6. AOBIOUS Inc.
• 7. Arbor Assays Inc.
• 8. Aviva Systems Biology Corporation
• 9. BBI Solutions OEM Limited
• 10. Bio-Rad Laboratories, Inc.
• 11. Bio-Techne Corporation
• 12. Biorbyt Ltd
• 13. BioVendor - Laboratorni medicina a.s.
• 14. Boditech Med Inc.
• 15. Cepham Life Sciences, Inc.
• 16. Cusabio Technology LLC
• 17. DIALAB GmbH
• 18. DiaSys Diagnostic Systems GmbH
• 19. Diazyme Laboratories, Inc. by General Atomics
• 20. Eagle Biosciences, Inc.
• 21. Elabscience Biotechnology Inc.
• 22. Ethos Biosciences, Inc.
• 23. Eurolyser Diagnostica GmbH by Mars, Incorporated
• 24. F. Hoffmann-La Roche Ltd
• 25. Fapon Biotech Inc.
• 26. Fortress Diagnostics Ltd.
• 27. Gentian Diagnostics ASA
• 28. Getein Biotech, Inc.
• 29. ImmunoDiagnostics Limited
• 30. Kamiya Biomedical Company
• 31. Laboratory Corporation of America Holdings
• 32. Merck KGaA
• 33. Proteintech Group, Inc.
• 34. PZ CORMAY S.A.
• 35. Randox Laboratories Ltd.
• 36. RayBiotech, Inc.
• 37. Sekisui Diagnostics, LLC
• 38. Siemens Healthineers AG
• 39. Sino Biological, Inc.
• 40. Thermo Fisher Scientific Inc.
• 41. Tosoh Corporation
• 42. Weldon Biotech
• 43. Zhejiang Kangte Biotechnology Co., Ltd.